IKARIAN CAPITAL

Ikarian Capital is a biotech investment firm focusing on innovations in drug discovery and development. Our team is led by professionals with deep scientific and biotech-specific finance backgrounds. We scour and select companies pursuing cutting edge science and demonstrating sound business fundamentals, spanning the spectrum of early- to late-stage clinical trials, agnostic to indication, market cap or geography. Our experience and nous in this space allows us to deploy transformation capital to support emerging companies over the long term and realize the promise of breakthrough science as they progress through the clinic. We pride ourselves on being selective and contrarian, backed up by our proprietary process that plays to our team's core expertise. We are committed to building an enduring business with strong values and high ethical standards.

Primary location: Dallas United States